DeepMed Research

Peking University Peoples Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Association Between Physical Activity Level ，Overall Muscle Strength and Pelvic Floor Muscle Function in Women.

Completed

Conditions: Pelvic Floor Muscle Weakness
Pelvic Floor Disorders

First Posted Date: 2022-04-08

Last Posted Date: 2023-02-06

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 929

Registration Number: NCT05318768

Locations: 🇨🇳
Peking University Peoples Hospital, Beijing, Beijing, China

Supraglottic Jet Oxygenation and Ventilation for Gastrointestinal Endoscopy at High-altitude

Not Applicable

Conditions: High Altitude
Hypoxia

Interventions: Procedure: Nasal cannula oxygen supply
Procedure: Supraglottic jet oxygenation and ventilation

First Posted Date: 2022-03-31

Last Posted Date: 2022-04-28

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 72

Registration Number: NCT05304923

Locations: 🇨🇳
Tibet autonomous region people's hospital, Lhasa, Tibet, China

Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Phase 2

Conditions: Immune Thrombocytopenia

Interventions: Drug: Iguratimod

First Posted Date: 2022-03-31

Last Posted Date: 2022-03-31

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 100

Registration Number: NCT05302024

Locations: 🇨🇳
Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China

A Study of Zanubrutinib in Patients With ITP

Phase 2

Completed

Conditions: Immune Thrombocytopenia
Bruton Tyrosine Kinase

Interventions: Drug: Zanubrutinib

First Posted Date: 2022-03-15

Last Posted Date: 2023-10-10

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 20

Registration Number: NCT05279872

Locations: 🇨🇳
Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China

The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Phase 2

Conditions: ITP
Immune Thrombocytopenia

Interventions: Drug: Iguratimod
Drug: Danazol

First Posted Date: 2022-03-15

Last Posted Date: 2022-05-02

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 120

Registration Number: NCT05281068

Locations: 🇨🇳
Zhuo-Yu An, Beijing, China
🇨🇳
Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, China

Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)

Phase 2

Completed

Conditions: Effect of Drug
Drug
Toxicity

Interventions: Drug: Apatinib+IE
Drug: IE

First Posted Date: 2022-03-14

Last Posted Date: 2024-07-31

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 81

Registration Number: NCT05277480

Locations: 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
🇨🇳
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China
🇨🇳
Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

and more 1 locations

Efficacy and Immunological Evaluation of Belimumab Plus Low Dose IL-2 in the Treatment of Systemic Lupus Erythematosus

Phase 3

Conditions: Systemic Lupus Erythematosus

Interventions: Drug: Belimumab
Drug: Interleukin-2

First Posted Date: 2022-03-02

Last Posted Date: 2022-03-25

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 10

Registration Number: NCT05262686

Locations: 🇨🇳
Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China

Postoperative Opioid Use and Ileus Occurrence---A Case Control Study

Completed

Conditions: Ileus
Opioid Use

Interventions: Other: ileus

First Posted Date: 2022-03-02

Last Posted Date: 2022-08-09

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 596

Registration Number: NCT05262569

Locations: 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China

Tetrandrine in the Treatment of Rheumatoid Arthritis

Not Applicable

Conditions: Rheumatoid Arthritis

Interventions: Drug: Tetrandrine
Drug: Placebo

First Posted Date: 2022-02-18

Last Posted Date: 2022-02-18

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 240

Registration Number: NCT05245448

Locations: 🇨🇳
Peking University People's Hospital, Beijing, China

Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening and Diagnosis of Breast Cancer

Recruiting

Conditions: Breast Neoplasms
Magnetic Resonance Imaging

Interventions: Diagnostic Test: MRI

First Posted Date: 2022-02-16

Last Posted Date: 2022-02-16

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 5000

Registration Number: NCT05243121

Locations: 🇨🇳
Peking university people's hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy